Specific clinical and immune features of CD68 in glioma via 1,024 samples

References

• ProsniakMHarshyneLAAndrewsDWGlioma grade is associated with the accumulation and activity of cells bearing M2 monocyte markersClin Cancer Res201319143776378623741072
   PubMed Web of Science ®Google Scholar
• KanuOOMehtaADiCGlioblastoma multiforme: a review of therapeutic targetsExpert Opin Ther Targets200913670171819409033
   PubMed Web of Science ®Google Scholar
• GrossmanSAYeXPiantadosiSDesideriSNaborsLBRosenfeldMFisherJNABTT CNS ConsortiumSurvival of patients with newly diagnosed glioblastoma treated with radiation and temozolomide in research studies in the United StatesClin Cancer Res20101682443244920371685
   PubMed Web of Science ®Google Scholar
• QuailDFBowmanRLAkkariLThe tumor microenvironment underlies acquired resistance to CSF-1R inhibition in gliomasScience20163526288aad301827199435
   PubMed Web of Science ®Google Scholar
• QuailDFJoyceJAMicroenvironmental regulation of tumor progression and metastasisNat Med201319111423143724202395
   PubMed Web of Science ®Google Scholar
• GolebiewskaABougnaudSStieberDSide population in human glioblastoma is non-tumorigenic and characterizes brain endothelial cellsBrain2013136Pt 51462147523460667
   PubMedGoogle Scholar
• SilverDJSinyukMVogelbaumMAAhluwaliaMSLathiaJDThe intersection of cancer, cancer stem cells, and the immune system: therapeutic opportunitiesNeuro Oncol201618215315926264894
   PubMed Web of Science ®Google Scholar
• PoonCCSarkarSYongVWKellyJJPGlioblastoma-associated microglia and macrophages: targets for therapies to improve prognosisBrain201714061548156028334886
   PubMedGoogle Scholar
• RuffellBCoussensLMMacrophages and therapeutic resistance in cancerCancer Cell201527446247225858805
   PubMed Web of Science ®Google Scholar
• YangLZhangYTumor-associated macrophages: from basic research to clinical applicationJ Hematol Oncol20171015828241846
   PubMed Web of Science ®Google Scholar
• Lu-EmersonCSnuderlMKirkpatrickNDIncrease in tumor-associated macrophages after antiangiogenic therapy is associated with poor survival among patients with recurrent glioblastomaNeuro Oncol20131581079108723828240
   PubMed Web of Science ®Google Scholar
• HeusinkveldMvan der BurgSHIdentification and manipulation of tumor associated macrophages in human cancersJ Transl Med2011921622176642
   PubMed Web of Science ®Google Scholar
• NyweningTMWang-GillamASanfordDETargeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trialLancet Oncol201617565166227055731
   PubMed Web of Science ®Google Scholar
• YangLWangFWangLCD163+ tumor-associated macrophage is a prognostic biomarker and is associated with therapeutic effect on malignant pleural effusion of lung cancer patientsOncotarget2015612105921060325871392
   PubMedGoogle Scholar
• RumneyRMHCoffeltSBNealeTADhayadeSTozerGMMillerGPyMT-Maclow: a novel, inducible, murine model for determining the role of CD68 positive cells in breast tumor developmentPLoS One20171212e018859129220404
   PubMed Web of Science ®Google Scholar
• OjalvoLSThompsonEDWangTLTumor-associated macrophages and the tumor immune microenvironment of primary and recurrent epithelial ovarian cancerHum Pathol20187413514729288043
   PubMed Web of Science ®Google Scholar
• HuseJTAldapeKDThe evolving role of molecular markers in the diagnosis and management of diffuse gliomaClin Cancer Res201420225601561125398843
   PubMed Web of Science ®Google Scholar
• VerhaakRGHoadleyKAPurdomECancer Genome Atlas Research NetworkIntegrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1Cancer Cell20101719811020129251
   PubMed Web of Science ®Google Scholar
• RodyAHoltrichUPusztaiLT-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancersBreast Cancer Res2009112R1519272155
   PubMed Web of Science ®Google Scholar
• RoeschSRappCDettlingSHerold-MendeCWhen immune cells turn bad-tumor-associated microglia/macrophages in gliomaInt J Mol Sci2018192436
   PubMed Web of Science ®Google Scholar
• KimJEPatelMAMangravitiACombination therapy with anti-PD-1, Anti-TIM-3, and focal radiation results in regression of murine gliomasClin Cancer Res201723112413627358487
   PubMed Web of Science ®Google Scholar
• HugoWZaretskyJMSunLGenomic and transcriptomic features of response to anti-PD-1 therapy in metastatic melanomaCell20161651354426997480
   PubMed Web of Science ®Google Scholar
• LiuSWangZWangYPD-1 related transcriptome profile and clinical outcome in diffuse gliomasOncoimmunology201772e138279229308304
   PubMed Web of Science ®Google Scholar
• LiGWangZZhangCMolecular and clinical characterization of TIM-3 in glioma through 1,024 samplesOncoimmunology201768e132833928919992
   PubMed Web of Science ®Google Scholar
• WangZZhangCLiuXMolecular and clinical characterization of PD-L1 expression at transcriptional level via 976 samples of brain gliomaOncoimmunology2016511e119631027999734
   PubMed Web of Science ®Google Scholar
• BaralAYeHXJiangPCYaoYMaoYB7-H3 and B7-H1 expression in cerebral spinal fluid and tumor tissue correlates with the malignancy grade of glioma patientsOncol Lett2014831195120125120686
   PubMed Web of Science ®Google Scholar
• YaoYYeHQiZB7-H4(B7x)-mediated cross-talk between glioma-initiating cells and macrophages via the IL6/JAK/STAT3 pathway lead to poor prognosis in glioma patientsClin Cancer Res201622112778279027001312
   PubMed Web of Science ®Google Scholar
• GieryngAPszczolkowskaDWalentynowiczKARajanWDKaminskaBImmune microenvironment of gliomasLab Invest201797549851828287634
   PubMed Web of Science ®Google Scholar
• HambardzumyanDGutmannDHKettenmannHThe role of microglia and macrophages in glioma maintenance and progressionNat Neurosci2016191202726713745
   PubMed Web of Science ®Google Scholar
• MoritaYZhangRLeslieMPathologic evaluation of tumor-associated macrophage density and vessel inflammation in invasive breast carcinomasOncol Lett20171422111211828789438
   PubMed Web of Science ®Google Scholar
• LeenstraSDasPKTroostDde BoerOJBoschDAHuman malignant astrocytes express macrophage phenotypeJ Neuroimmunol199556117257822478
   PubMed Web of Science ®Google Scholar
• SharmaABendreAMondalAMuzumdarDGoelNShirasAAngiogenic gene signature derived from subtype specific cell models segregate proneural and mesenchymal glioblastomaFront Oncol2017714628744448
   PubMed Web of Science ®Google Scholar
• PollardJWTumour-educated macrophages promote tumour progression and metastasisNat Rev Cancer200441717814708027
   PubMed Web of Science ®Google Scholar
• LuksikASMaxwellRGarzon-MuvdiTLimMThe role of immune checkpoint inhibition in the treatment of brain tumorsNeurotherapeutics20171441049106528258545
   PubMed Web of Science ®Google Scholar
• StrojnikTKavalarRZajcIDiamandisEPOikonomopoulouKLahTTPrognostic impact of CD68 and kallikrein 6 in human gliomaAnticancer Res20092983269327919661345
   PubMed Web of Science ®Google Scholar